BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, June 1, 2026
Home » Topics » Science

Science
Science RSS Feed RSS

BioWorld MedTech’s Diagnostics Extra for July 9, 2020

July 9, 2020
By Meg Bryant and Anette Breindl
Keeping you up to date on recent developments in diagnostics, including: Diagnosing fatty liver disease; Assessing COVID-19 with lung ultrasound; Noncoding mutations contribute to heart disease.
Read More
Blood count infographic
Blood sport

Liver protein improves brain function after exercise, but remember Ember

July 9, 2020
By Anette Breindl
Exercise is a powerful way to keep the elderly brain working well, not just in individuals that are healthy, but also in those with neurodegenerative disease. Even individuals with familial Alzheimer’s, though they will develop dementia regardless of whether they exercise or not, will have relatively better cognitive function if they exercise than if they don’t.
Read More

BioWorld MedTech’s Orthopedics Extra for July 8, 2020

July 8, 2020
By Holland Johnson
Keeping you up to date on recent developments in orthopedics, including: Buzzing to rebuild broken bone; Tiny mineral particles are better vehicles for promising gene therapy; New trial results question standard treatment plan for rheumatoid arthritis.
Read More
HIV encased in multiple structures including the capsid (blue)

AIDS2020: Virtual: Can state of the ART get to ‘see you next year’?

July 8, 2020
By Anette Breindl
Forty years after HIV became a global pandemic, there are now more than 30 drugs approved to treat it. The National Institute of Allergy and Infectious Diseases’ director, Anthony Fauci, and clinical director, Clifford Lane, opined in the July 2, 2020, issue of The New England Journal of Medicine that “considering the spectacular scientific advances that have been made over nearly four decades, it is conceivable that with optimal implementation of available prevention strategies and treatments, the end of HIV/AIDS as a global pandemic will be attainable.”
Read More
Herd immunity illustration

COVID-19: Trying for herd immunity without vaccine ‘unethical’ and ‘unachievable’

July 7, 2020
By Anette Breindl
A large epidemiological study published in the July 6, 2020, advance online issue of The Lancet found that most individuals who became infected with SARS-CoV-2 developed antibodies to the virus, confirming that infection usually results in at least a short-term immune response.
Read More

BioWorld MedTech’s Oncology Extra for July 7, 2020

July 7, 2020
By Mark McCarty
Keeping you up to date on recent developments in oncology, including: Researchers float ChIA PET as answer to prostate cancer puzzle; Dana-Farber offers liquid biopsy for renal cell carcinoma; Inhaled indocyanine green may enable lung tumor margin depiction.
Read More
Herd immunity illustration

COVID-19: Trying for herd immunity without vaccine ‘unethical’ and ‘unachievable’

July 6, 2020
By Anette Breindl
A large epidemiological study published in the July 6, 2020, advance online issue of The Lancet found that most individuals who became infected with SARS-CoV-2 developed antibodies to the virus, confirming that infection usually results in at least a short-term immune response.
Read More

BioWorld MedTech’s Cardiology Extra for July 6, 2020

July 6, 2020
By Liz Hollis and Anette Breindl
Keeping you up to date on recent developments in cardiology, including: Potassium channel distancing fights stroke; Examining ischemic stroke in patients with COVID-19 vs. those with influenza; COVID-19 infects heart cells in lab dish.
Read More

BioWorld MedTech’s Diagnostics Extra for July 2, 2020

July 2, 2020
By Meg Bryant and Anette Breindl
Keeping you up to date on recent developments in diagnostics, including: Broad scale genomic testing for childhood illness; Deep learning model for cancer prognosis; Placenta attachment theory.
Read More
CD47 protein structure
CD47 strikes again

Immune checks and balances evident from earliest stages of infection

July 2, 2020
By Anette Breindl
The checkpoint molecule CD47 has high hopes riding on it in oncology as being the innate immune equivalent of PD-1. Multiple companies are developing blockers against CD47 and/or its ligand, SIRPa, for the treatment of various tumors.
Read More
Previous 1 2 … 151 152 153 154 155 156 157 158 159 … 197 198 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 29, 2026.
  • Floating antibody drug conjugates

    TROP2 ADCs progress into first-line for lung, breast cancers

    BioWorld
    Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
  • Illustration of antibodies and viral infection

    New evidence links autoimmunity to long COVID symptoms

    BioWorld
    Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
  • Digital brain and silhouette

    Will Ovid’s golden age of KCC2 metamorph CNS?

    BioWorld
    The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
  • Liver with hepatitis viruses, blood cells

    Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections

    BioWorld
    GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing